Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12626001133325) titled 'Evaluating safe ketone thresholds to minimise ketosis in young people with Type 1 Diaberes using Dapagliflozin (KETO-TRACK)' on Sept. 11.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Parallel
Type of endpoint: Safety/efficacy
Primary Sponsor: The Kids Research Institute Australia
Condition:
Blood glucose control
Type 1 Diabetes Mellitus
Blood glucose control
Type 1 Diabetes Mellitus
Metabolic and Endocrine - Diabetes
Intervention:
Dapagliflozin is a SGLT2 inhibitor (SGLT2i) with the potential to improve...